SCHEMBL25313236

SCHEMBL25313236

O=C(c1cccc(Nc2ccccc2)n1)N1CCNCC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.50
POLB P06746 3/20 0.49
GNE Q9Y223 1/20 0.47
KMT2A Q03164 2/20 0.46
KDM4E B2RXH2 1/20 0.46
MEN1 O00255 1/20 0.46
MAPT P10636 1/20 0.46
ALPG P10696 1/20 0.46
RAB9A P51151 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
MKNK2 Q9HBH9 2/20 0.46
CCNC P24863 4/20 0.45
CDK8 P49336 4/20 0.45
GRM5 P41594 1/20 0.44
LANCL2 Q9NS86 1/20 0.43
ALDH1A1 P00352 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
ATR Q13535 1/20 0.42
HRH4 Q9H3N8 1/20 0.42
HRH3 Q9Y5N1 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25312498 0.90 MAPT (0.53) POLBGNEKMT2AKDM4EMEN1
SCHEMBL25311173 0.88 CYP2D6 (0.56) ALDH1A1
SCHEMBL25311390 0.86 GNE (0.49) POLBGNEKMT2AKDM4EMEN1
SCHEMBL25311436 0.84 CYP2C19 (0.50) GNEKMT2AKDM4EMEN1MAPT
SCHEMBL25310693 0.82 GNE (0.45) GNEKMT2AKDM4EMEN1MAPT
SCHEMBL7245767 0.81 GNE (0.62) SIGMAR1GNEMKNK2LANCL2ALDH1A1
SCHEMBL25878262 0.81 MEN1 (0.49) POLBGNEKMT2AKDM4EMEN1
SCHEMBL29466326 0.81 MEN1 (0.49) POLBGNEKMT2AKDM4EMEN1
SCHEMBL29484593 0.81 CHRNA4 (0.57) KMT2AKDM4EMEN1MAPTALPG
SCHEMBL25883039 0.81 CHRNA4 (0.57) KMT2AKDM4EMEN1MAPTALPG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240101552-A1 CARBONYL HETEROCYCLIC COMPOUND AND APPLICATION THEREOF SHANGHAI PHARMACEUTICALS HOLDING CO., LTD. (CN) 2024-03-28 US disclosed
EP-4215526-A1 CARBONYL HETEROCYCLIC COMPOUND AND APPLICATION THEREOF Shanghai Pharmaceuticals Holding Co., Ltd. (CN) 2023-07-26 EP disclosed
WO-2022057932-A1 CARBONYL HETEROCYCLIC COMPOUND AND APPLICATION THEREOF 上海医药集团股份有限公司 2022-03-24 WO disclosed
WO-2022057928-A1 CARBONYL HETEROCYCLIC COMPOUND AND APPLICATION THEREOF 上海医药集团股份有限公司 2022-03-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240101552-A1 CARBONYL HETEROCYCLIC COMPOUND AND APPLICATION THEREOF LANCL2, CBS, LCP2 SIGMAR1 4316/4885POLB 4626/4885GNE 1441/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.